County of Titus v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:17-op-45161 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Dec 21, 2017 |
| Case in other court: | Texas Eastern, 5:17-cv-00189 |
| Last checked: Friday Nov 08, 2019 4:55 PM EST |
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Morris & Dickson Co., LLC
|
|
|
Defendant
Mylan Pharmaceuticals Inc.
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Par Pharmaceutical Companies, Inc.
|
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Sandoz Inc.
|
|
|
Defendant
Smith Drug Company
|
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Wal-Mart Stores Texas, LLC
|
|
|
Defendant
Walgreen Co.
|
Represented By
|
|
Defendant
Walmart Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Allergan Finance LLC
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
|
Defendant
CVS Health Corporation
|
|
|
Defendant
CVS Pharmacy, Inc.
|
|
|
Defendant
Does 1-100, Inclusive
|
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Hikma Pharmaceuticals USA Inc.
|
|
|
Defendant
Indivior Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Plaintiff
County of Titus
|
Represented By
|
| TERMINATED PARTIES | |
|
Defendant
Knoll Pharmaceutical Company
Terminated: 03/23/2018
|
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
Terminated: 04/11/2018
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
Abbott Laboratories
Terminated: 03/01/2018
|
Represented By
|
|
Defendant
Cephalon Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
Terminated: 03/24/2018
|
Represented By
|
| Docket last updated: 04/08/2019 5:36 PM EDT |
| Wednesday, November 08, 2017 | ||
| Case Assigned to Presiding Judge Robert W. Schroeder, III. (slo, ) [Transferred from txed on 12/21/2017.] | ||
| In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form[LINK:Consent to Proceed Before Magistrate Judge] is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge . (slo, ) [Transferred from txed on 12/21/2017.] | ||
| 1 | 1
COMPLAINT AND JURY DEMAND against All Defendants ( Filing fee $ 400 receipt number 0540-6544926.), filed by County of Titus.(Simon, Jeffrey) [Transferred from txed on 12/21/2017.]
|
|
|
Att: 1
Civil Cover Sheet
|
||
| Thursday, November 09, 2017 | ||
| 2 | 2
SUMMONS Issued as to Abbott Laboratories, Actavis LLC, Actavis Pharma, Inc., Allergan Finance LLC, AmerisourceBergen Corporation, Cardinal Health, Inc., Cephalon Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Knoll Pharmaceutical Company, McKesson Corporation, Purdue Pharma Inc, Purdue Pharma L.P., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Watson Laboratories, Inc.(slo, ) [Transferred from txed on 12/21/2017.]
|
|
|
Att: 1
Summons-Abbott Laboratories,
|
||
|
Att: 2
Summons-Actavis LLC,
|
||
|
Att: 3
Summons-Actavis Pharma Inc,
|
||
|
Att: 4
Summons-Allergan Finance LLC,
|
||
|
Att: 5
Summons-AmerisourceBergen Corporation,
|
||
|
Att: 6
Summons-Cardinal Health Inc,
|
||
|
Att: 7
Summons-Cephalon Inc,
|
||
|
Att: 8
Summons-Endo Health Solutions Inc,
|
||
|
Att: 9
Summons-Endo Pharmaceuticals Inc,
|
||
|
Att: 10
Summons-Insys Therapeutics Inc,
|
||
|
Att: 11
Summons-Janssen Pharmaceuticals Inc,
|
||
|
Att: 12
Summons-Johnson & Johnson,
|
||
|
Att: 13
Summmons-Knoll Pharmaceuticals Company,
|
||
|
Att: 14
Summons-McKesson Corporation,
|
||
|
Att: 15
Summons-Purdue Pharma Inc,
|
||
|
Att: 16
Summons-Teva Pharmaceuticals USA,
|
||
|
Att: 17
Summons-The Purdue Frederick Company,
|
||
|
Att: 18
Summons-Watson Laboratories
|
||
| 3 | 3
NOTICE of Attorney Appearance by John F Walker on behalf of County of Titus (Walker, John) [Transferred from txed on 12/21/2017.]
|
|
| 4 | 4
NOTICE of Attorney Appearance by Reid William Martin on behalf of County of Titus (Martin, Reid) [Transferred from txed on 12/21/2017.]
|
|
| Thursday, November 16, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for McKesson Corporation to 1/4/2018. 30 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for McKesson Corporation to 1/19/2018. 15 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/21/2017.] | ||
| 5 | 5
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/21/2017.]
|
|
| 6 | 6
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/21/2017.]
|
|
| Tuesday, November 21, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 1/19/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| 7 | 7
NOTICE of Attorney Appearance by Amy M. Carter on behalf of County of Titus (Carter, Amy) [Transferred from txed on 12/21/2017.]
|
|
| 8 | 8
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/21/2017.]
|
|
| 9 | 9
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/21/2017.]
|
|
| Wednesday, November 22, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 1/5/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| 10 | 10
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/21/2017.]
|
|
| 11 | 11
First MOTION for Extension of Time to File Answer by Abbott Laboratories.(Ertas, Alper) [Transferred from txed on 12/21/2017.]
|
|
|
Att: 1
Text of Proposed Order
|
||
| Monday, November 27, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Knoll Pharmaceutical Company to 1/5/2018. 28 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| 12 | 12
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Knoll Pharmaceutical Company.( Wilkes, John) [Transferred from txed on 12/21/2017.]
|
|
| 13 | 13
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc.( Sarokhanian, Nicholas) [Transferred from txed on 12/21/2017.]
|
|
| 14 | 14
CORPORATE DISCLOSURE STATEMENT filed by Insys Therapeutics, Inc. (Sarokhanian, Nicholas) [Transferred from txed on 12/21/2017.]
|
|
| 15 | 15
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/21/2017.]
|
|
| 16 | 16
First MOTION for Extension of Time to File Answer re11 First MOTION for Extension of Time to File Answer by Abbott Laboratories.(Ertas, Alper) [Transferred from txed on 12/21/2017.]
|
|
|
Att: 1
Text of Proposed Order
|
||
| Tuesday, November 28, 2017 | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 1/20/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| 17 | 17
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 18 | 18
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 19 | 19
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 20 | 20
CORPORATE DISCLOSURE STATEMENT filed by Purdue Pharma Inc, Purdue Pharma L.P., The Purdue Frederick Company [Transferred from txed on 12/21/2017.]
|
|
| 21 | 21
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 22 | 22
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 23 | 23
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| Wednesday, November 29, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma Inc to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for The Purdue Frederick Company to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma Inc to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for The Purdue Frederick Company to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Thursday, November 30, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Allergan Finance LLC to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Allergan Finance LLC to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| 24 | 24
CORPORATE DISCLOSURE STATEMENT filed by AmerisourceBergen Corporation (Smith, Melissa) [Transferred from txed on 12/21/2017.]
|
|
| 25 | 25
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/21/2017.]
|
|
| 26 | 26
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/21/2017.]
|
|
| Friday, December 01, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Health Solutions Inc. to 1/5/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Pharmaceuticals Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Health Solutions Inc. to 1/22/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Pharmaceuticals Inc. to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| ***FILED IN ERROR. Document # 32, Application. PLEASE IGNORE. ATTORNEY TO REFILE. *** (slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Actavis LLC to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Cephalon Inc. to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Watson Laboratories, Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Teva Pharmaceuticals USA, Inc. to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| 27 | 27
CORPORATE DISCLOSURE STATEMENT filed by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Sibiski, Hannah) [Transferred from txed on 12/21/2017.]
|
|
| 28 | 28
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Health Solutions Inc..(Sibiski, Hannah) [Transferred from txed on 12/21/2017.]
|
|
| 29 | 29
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals Inc..(Sibiski, Hannah) [Transferred from txed on 12/21/2017.]
|
|
| 30 | 30
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Health Solutions Inc..(Sibiski, Hannah) [Transferred from txed on 12/21/2017.]
|
|
| 31 | 31
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals Inc..(Sibiski, Hannah) [Transferred from txed on 12/21/2017.]
|
|
| 32 | 32
FILED IN ERROR, PER ATTORNEY. PLEASE IGNORE. Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Insys Therapeutics, Inc.(Sarokhanian, Nicholas) Modified on 12/1/2017 (slo, ). [Transferred from txed on 12/21/2017.]
|
|
| 33 | 33
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis LLC.( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 34 | 34
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cephalon Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 35 | 35
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Watson Laboratories, Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 36 | 36
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Teva Pharmaceuticals USA, Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 37 | 37
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis Pharma, Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 38 | 38
CORPORATE DISCLOSURE STATEMENT filed by Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc. identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc.. (Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 39 | 39
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc.(Sarokhanian, Nicholas) [Transferred from txed on 12/21/2017.]
|
|
| 40 | 40
CORPORATE DISCLOSURE STATEMENT filed by Cephalon Inc., Teva Pharmaceuticals USA, Inc. (Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| Monday, December 04, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Actavis Pharma, Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Johnson & Johnson to 12/29/2017. 28 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Ortho-McNeil-Janssen Pharmaceuticals, Inc. to 12/29/2017. 25 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Janssen Pharmaceutica Inc. to 12/29/2017. 25 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Janssen Pharmaceuticals, Inc. to 12/29/2017. 25 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/21/2017.] | ||
| 41 | 41
NOTICE of Attorney Appearance by Stephen Edward McConnico on behalf of Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 12/21/2017.]
|
|
| 42 | 42
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/21/2017.]
|
|
| 43 | 43
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Johnson & Johnson.( McConnico, Stephen) [Transferred from txed on 12/21/2017.]
|
|
| 44 | 44
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Ortho-McNeil-Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/21/2017.]
|
|
| 45 | 45
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceutica Inc..( McConnico, Stephen) [Transferred from txed on 12/21/2017.]
|
|
| 46 | 46
CORPORATE DISCLOSURE STATEMENT filed by Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 12/21/2017.]
|
|
| Thursday, December 07, 2017 | ||
| 47 | 47
NOTICE of Attorney Appearance - Pro Hac Vice by James K. O'Connor on behalf of Abbott Laboratories. Filing fee $ 100, receipt number 0540-6579570. (O'Connor, James) [Transferred from txed on 12/21/2017.]
|
|
| 48 | 48
NOTICE of Attorney Appearance - Pro Hac Vice by John A McCauley on behalf of Abbott Laboratories. Filing fee $ 100, receipt number 0540-6579850. (McCauley, John) [Transferred from txed on 12/21/2017.]
|
|
| Friday, December 15, 2017 | ||
| 49 | 49
CERTIFIED CONDITIONAL MDL TRANSFER ORDER (CTO-1)transferring to the Northern District of Ohio. (lfs, ) Modified on 12/18/2017 (lfs, ). [Transferred from txed on 12/21/2017.]
|
|
| Monday, December 18, 2017 | ||
| Interdistrict transfer to the Northern District District of Ohio per Certified MDL Conditional Transfer Order. (lfs, ) [Transferred from txed on 12/21/2017.] | ||
| Thursday, December 21, 2017 | ||
| 50 | 50
CASE TRANSFERRED IN from District of Texas Eastern. Case number 5:17-cv-00189. Original file, certified copy of transfer order and docket sheet received.
|
|